Neoadjuvant Chemotherapy Combined With Cetuximab for EGFR Wild Type Locally Advanced Rectal Cancer
Clinical trial NCT03391843 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03391843
- Sponsor
- RenJi Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2027-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.